Literature DB >> 34185632

Is 'original antigenic sin' complicating indian vaccination drive against Covid-19?

Vipin M Vashishtha1.   

Abstract

India is in the grip of a devastating second wave of Covid-19. Many experts believe new variants of concern (VOC) are behind this unprecedented surge. Some media reports are hinting toward higher risk of Covid infection following Covid vaccinations. 'Original antigenic sin,' in which a prior exposure to an antigen leads to an ineffective response to a related antigen, may offer one immunological explanation for this unusual association. There is an urgent need of undertaking a detailed study to prove/disprove this association.

Entities:  

Keywords:  Covid-19; original antigenic sin; vaccines

Mesh:

Substances:

Year:  2021        PMID: 34185632      PMCID: PMC8437463          DOI: 10.1080/21645515.2021.1945904

Source DB:  PubMed          Journal:  Hum Vaccin Immunother        ISSN: 2164-5515            Impact factor:   4.526


  4 in total

Review 1.  Original Antigenic Sin: How First Exposure Shapes Lifelong Anti-Influenza Virus Immune Responses.

Authors:  Ali Zhang; Hannah D Stacey; Caitlin E Mullarkey; Matthew S Miller
Journal:  J Immunol       Date:  2019-01-15       Impact factor: 5.422

2.  Association between the 2008-09 seasonal influenza vaccine and pandemic H1N1 illness during Spring-Summer 2009: four observational studies from Canada.

Authors:  Danuta M Skowronski; Gaston De Serres; Natasha S Crowcroft; Naveed Z Janjua; Nicole Boulianne; Travis S Hottes; Laura C Rosella; James A Dickinson; Rodica Gilca; Pam Sethi; Najwa Ouhoummane; Donald J Willison; Isabelle Rouleau; Martin Petric; Kevin Fonseca; Steven J Drews; Anuradha Rebbapragada; Hugues Charest; Marie-Eve Hamelin; Guy Boivin; Jennifer L Gardy; Yan Li; Trijntje L Kwindt; David M Patrick; Robert C Brunham
Journal:  PLoS Med       Date:  2010-04-06       Impact factor: 11.069

3.  Tortoises, hares, and vaccines: A cautionary note for SARS-CoV-2 vaccine development.

Authors:  Gregory A Poland
Journal:  Vaccine       Date:  2020-05-01       Impact factor: 3.641

4.  Development of SARS-CoV-2 vaccines: challenges, risks, and the way forward.

Authors:  Vipin M Vashishtha; Puneet Kumar
Journal:  Hum Vaccin Immunother       Date:  2020-12-03       Impact factor: 3.452

  4 in total
  2 in total

1.  Seasonal coronaviruses and SARS-CoV-2: effects of preexisting immunity during the COVID-19 pandemic.

Authors:  Gang Wang; Ze Xiang; Wei Wang; Zhi Chen
Journal:  J Zhejiang Univ Sci B       Date:  2022-06-15       Impact factor: 5.552

2.  SARS-CoV-2 Spike Protein Vaccine-Induced Immune Imprinting Reduces Nucleocapsid Protein Antibody Response in SARS-CoV-2 Infection.

Authors:  Juan F Delgado; Mónica Vidal-Pla; M Carmen Moya; Mateu Espasa; Antonio Casabella; Manel Seda; Joan Calvet; Jordi Gratacós; Rosa M Serrano; Pilar Peña
Journal:  J Immunol Res       Date:  2022-07-29       Impact factor: 4.493

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.